Literature DB >> 23611029

An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss.

Averil D Reus1, Nicole M van Besouw, Nikki M Molenaar, Eric A P Steegers, Willy Visser, Ronella P de Kuiper, Ronald R de Krijger, Dave L Roelen, Niek Exalto.   

Abstract

PROBLEM: Chronic histiocytic intervillositis (CHIV) is a rare type of placental pathology that is associated with reproductive loss at all gestational ages. The aim of the study was to investigate the relationship between the severity of CHIV and the outcome of pregnancy and to compare the immune response between CHIV patients and controls to explore an immunological origin of CHIV. METHOD OF STUDY: Microscopic slides were reviewed and scored according to a previously published grading system in 30 pregnancies of 22 CHIV patients. Partner-specific mixed lymphocyte reactions, cytotoxic T-lymphocyte precursor frequencies (CTLpf), and anti-HLA antibodies were determined in four patients and seven controls.
RESULTS: Higher CHIV scores are associated with worse pregnancy outcome. CHIV patients demonstrated a higher CTLpf against their partner compared to non-complicated pregnancies (P = 0.03). The CTLpf was extremely high in 75% of the patients. Antipaternal HLA antibodies were only present in 75% of the CHIV patients compared to none of the controls (P = 0.02).
CONCLUSION: CHIV scores seem to be associated with the severity of adverse pregnancy outcome. High antipaternal cellular (T-cell) and humoral (B-cell) response to partner-specific CTLpf and the presence of anti-HLA antibodies directed to the partner suggest an immunologic origin of CHIV.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Adverse pregnancy outcome; chronic histiocytic intervillositis; immunology; miscarriage

Mesh:

Substances:

Year:  2013        PMID: 23611029     DOI: 10.1111/aji.12125

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

1.  High mobility group box 1 protein polymorphism affects susceptibility to recurrent pregnancy loss by up-regulating gene expression in chorionic villi.

Authors:  Hua Jin; Jie Wu; Qiuhong Yang; Yan Cai; Wenxiu He; Cuiying Liu
Journal:  J Assist Reprod Genet       Date:  2015-05-10       Impact factor: 3.412

2.  One-Sided Chronic Intervillositis of Unknown Etiology in Dizygotic Twins: A Description of 3 Cases.

Authors:  Lotte E van der Meeren; Juliette Krop; Kyra L Dijkstra; Kitty W M Bloemenkamp; Emily F Cornish; Peter G J Nikkels; Marie-Louise P van der Hoorn; Manon Bos
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 3.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 4.  Evidence-based management of recurrent miscarriages.

Authors:  Yadava B Jeve; William Davies
Journal:  J Hum Reprod Sci       Date:  2014-07

5.  Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis.

Authors:  Chloe A Brady; Charlotte Williams; Gauri Batra; Elaine Church; Clare L Tower; Ian P Crocker; Alexander E P Heazell
Journal:  Front Med (Lausanne)       Date:  2021-10-18

6.  The Missing Role of Prenatal Diagnosis of Chronic Histiocytic Intervillositis in the Management of Growth Restricted Fetuses.

Authors:  Sedigheh Hantoushzadeh; Maasoumeh Saleh; Sepehr Aghajanian; Behnaz Nouri
Journal:  Front Med (Lausanne)       Date:  2022-02-02

7.  Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.

Authors:  Laurel Moar; Chloe Simela; Surabhi Nanda; Andreas Marnerides; Mudher Al-Adnani; Catherine Nelson-Piercy; Kypros H Nicolaides; Panicos Shangaris
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.